Molecular pharmacology of 4-substituted glutamic acid analogues at ionotropic and metabotropic excitatory amino acid receptors
Section snippets
Acknowledgements
The authors wish to thank Professor Shigetada Nakanishi (Kyoto University, Japan) for his generous gift of mGlu expressing cell lines and Ms. Heidi Petersen for technical assistance. This work was supported by H. Lundbeck A/S, The Lundbeck Foundation and The Danish State Biotechnology Program.
References (8)
- et al.
Design of excitatory amino acid receptor agonists, partial agonists and antagonists: Ibotenic acid as a key lead structure
Eur. J. Med. Chem.
(1996) - et al.
Conformational analysis of glutamic acid analogues as probes of glutamate receptors using molecular modelling and NMR methods. Comparison with specific agonists
Bioorg. Med. Chem.
(1997) - et al.
A new highly selective metabotropic excitatory amino acid agonist: 2-amino-4-(3-hydroxy-5-methylisoxazol-4-yl)butyric acid
J. Med. Chem.
(1996) - et al.
Efficient synthesis of 4-methylene-l-glutamic acid and its cyclopropyl analogue
Tetrahedron Asymmetry
(1994)
Cited by (29)
Pharmacological characterization of (4R)-alkyl glutamate analogues at the ionotropic glutamate receptors - Focus on subtypes iGlu<inf>5-7</inf>
2009, European Journal of PharmacologyChiral liquid chromatography-mass spectrometry for high-throughput screening of enzymatic racemase activity
2003, Journal of Chromatography ASYM 2081, an agonist that desensitizes kainate receptors, attenuates capsaicin and inflammatory hyperalgesia
2003, Brain ResearchCitation Excerpt :We cannot rule out the possibility that at doses used in the present study, SYM 2081 may have bound to and been an agonist at AMPA, NMDA, or metabotrophic glutamate receptors. SYM 2081 has been shown to induce inward currents at AMPA (GluR1 and GluR3) and metabotrophic glutamate receptor subunits (mGluR1a, mGluR2, mGluR4a) expressed heterogeneously but at 1500-fold higher concentrations than required to evoke currents at the kainate receptor subunit (GluR5) that were similarly expressed [7,20,68]. Whether SYM 2081 evokes currents through NMDA receptors is unknown.
Synthesis and receptor binding affinity of new selective GluR5 ligands
2001, Bioorganic and Medicinal ChemistryExcitatory amino acid agonists and antagonists: Pharmacology and therapeutic applications
2000, Pharmaceutica Acta HelvetiaeFirst enantiospecific synthesis of a 3,4-dihydroxy-L-glutamic acid [(3S,4S)-DHGA], a new mGluR1 agonist
2000, Bioorganic and Medicinal Chemistry Letters